European Journal of Endocrinology, 2022
Novel inflammatory biomarkers in thyroid eye disease

Ueland H., Ueland G., Løvås K. et al.

Frontiers in Neurology, 2022
Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease

Carlyle B., Kitchen R., Mattingly Z. et al.

Nature Medicine, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Padrón L., Maurer D., O’Hara M. et al.

BMC Women's Health, 2022
Applicability of polygenic risk scores in endometriosis clinical presentation

Svensson A., Garcia-Etxebarria K., Åkesson A. et al.

Brain, 2022
A Mendelian randomization study investigating the causal role of inflammation on Parkinson’s disease

Bottigliengo D., Foco L., Seibler P. et al.

Kidney Medicine, 2022
Plasma Kidney Injury Molecule-1 in Systemic Lupus Erythematosus: Discordance Between ELISA and Proximity Extension Assay

Schmidt I., Colona M., Srivastava A. et al.

Scandinavian Journal of Immunology, 2022
The Karolinska KI/K COVID‐19 immune atlas: An open resource for immunological research and educational purposes

Ljunggren H., Heggernes Ask E., Cornillet M. et al.

Nature Communications, 2022
Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

Liu J., Wang Y., Tian Z. et al.

Annals of Oncology, 2022
Impact of acetaminophen on the efficacy of immunotherapy in cancer patients

Bessede A., Marabelle A., Guégan J. et al.

Multiple Sclerosis and Related Disorders, 2022
Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL

Gawde S., Agasing A., Bhatt N. et al.

Molecular Psychiatry, 2022
Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia

Mätlik K., Garton D., Montaño-Rodríguez A. et al.

Annals of the Rheumatic Diseases, 2022
Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus

Dörner T., Tanaka Y., Dow E. et al.

Osteoporosis International, 2022
Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty—results from a randomized placebo-controlled clinical trial

Sköld C., Kultima K., Freyhult E. et al.

PLOS ONE, 2022
Genetically regulated gene expression and proteins revealed discordant effects

Pott J., Garcia T., Hauck S. et al.

PROTEOMICS, 2022
Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms

Haslam D., Li J., Dillon S. et al.

eBioMedicine, 2022
The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study

Jones D., Wetten A., Barron-Millar B. et al.

European Journal of Heart Failure, 2022
Distinct pathophysiological pathways in women and men with heart failure

Ravera A., Santema B., de Boer R. et al.

Scientific Reports, 2022
Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction

Girerd N., Cleland J., Anker S. et al.

Pediatric Research, 2022
Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia

Kindt A., Förster K., Cochius-den Otter S. et al.

Scientific Reports, 2022
Corticotropin releasing hormone as an identifier of bronchiolitis obliterans syndrome

Niroomand A., Ghaidan H., Hallgren O. et al.